| User's Publication |
|
21570
Shirasaka Y, Yamada K, Etoh T, Noguchi K, Hasegawa T, Ogawa K, Kobayashi T, Nishizono A, Inomata M.
Cytocidal Effect of Irradiation on Gastric Cancer Cells Infected with a Recombinant Mammalian Orthoreovirus Expressing a Membrane-Targeted KillerRed.
Pharmaceuticals (Basel)
2024
17(1)
PubMed ID: 38256912
DOI: 10.3390/ph17010079
|
|
19687
Mori Y, Nishikawa SG, Fratiloiu AR, Tsutsui M, Kataoka H, Joh T, Johnston RN.
Modulation of Reoviral Cytolysis (I): Combination Therapeutics
Viruses
2023
15(7):1472
PubMed ID: 37515160
DOI: 10.3390/v15071472
|
|
19729
Sato T, Saito M, Nakajima S, Saito K, Katagata M, Fukai S, Okayama H, Sakamoto W, Saze Z, Momma T, Mimura K, Kono K.
ARID1A deficiency is targetable by AKT inhibitors in HER2-negative gastric cancer
Gastric Cancer
2023
26(3):379-392
PubMed ID: 36811690
DOI: 10.1007/s10120-023-01373-6
|
|
19939
hiozaki A, Fukami T, Shimizu H, Kosuga T, Kudou M, Takemoto K, Katsurahara K, Nishibeppu K, Ohashi T, Arita T, Konishi H, Komatsu S, Kubota T, Fujiwara H, Otsuji E.
Effects of TRPV2 on the Expression of PD-L1 and Its Binding Ability to PD-1 in Gastric Cancer
Ann Surg Oncol
2023
30(13):8704-8716
PubMed ID: 37599296
DOI: 10.1245/s10434-023-14084-0
|
|
19973
Fukai S, Nakajima S, Saito M, Saito K, Kase K, Nakano H, Sato T, Sakuma M, Kaneta A, Okayama H, Mimura K, Sakamoto W, Saze Z, Momma T, Kono K.
Down-regulation of stimulator of interferon genes (STING) expression and CD8+ T-cell infiltration depending on HER2 heterogeneity in HER2-positive gastric cancer
Gastric Cancer
2023
26(6):878-890
PubMed ID: 37542528
DOI: 10.1007/s10120-023-01417-x
|
|
21486
Lou M, Iwatsuki M, Wu X, Zhang W, Matsumoto C, Baba H.
Cancer-Associated Fibroblast-Derived IL-8 Upregulates PD-L1 Expression in Gastric Cancer Through the NF-κB Pathway.
Ann Surg Oncol
2023
PubMed ID: 38006530
DOI: 10.1245/s10434-023-14586-x
|
|
17567
Takashima Y, Komatsu S, Ohashi T, Kiuchi J, Kamiya H, Shimizu H, Arita T, Konishi H, Shiozaki A, Kubota T, Okamoto K, Fujiwara H, Tsuda H, Otsuji E.
Overexpression of Tetraspanin31 contributes to malignant potential and poor outcomes in gastric cancer
Cancer Sci
2022
113(6):1984-1998
PubMed ID: 35307915
DOI: 10.1111/cas.15342
|
|
20459
Kato S, Shiozaki A, Kudou M, Shimizu H, Kosuga T, Ohashi T, Arita T, Konishi H, Komatsu S, Kubota T, Fujiwara H, Okamoto K, Kishimoto M, Konishi E, Otsuji E.
TRPV2 Promotes Cell Migration and Invasion in Gastric Cancer via the Transforming Growth Factor-β Signaling Pathway.
Ann Surg Oncol
2022
PubMed ID: 34855064
DOI: 10.1245/s10434-021-11132-5
|
|
20571
Fu L, Yonemura A, Yasuda-Yoshihara N, Umemoto T, Zhang J, Yasuda T, Uchihara T, Akiyama T, Kitamura F, Yamashita K, Okamoto Y, Bu L, Wei F, Hu X, Liu Y, Ajani JA, Tan P, Baba H, Ishimoto T.
Intracellular MUC20 variant 2 maintains mitochondrial calcium homeostasis and enhances drug resistance in gastric cancer.
Gastric Cancer
2022
PubMed ID: 35166958
DOI: 10.1007/s10120-022-01283-z
|
|
20622
Takaki W, Konishi H, Matsubara D, Shoda K, Arita T, Kataoka S, Shibamoto J, Furuke H, Takabatake K, Shimizu H, Komatsu S, Shiozaki A, Kubota T, Okamoto K, Otsuji E.
Role of Extracellular High-Mobility Group Box-1 as a Therapeutic Target of Gastric Cancer.
Int J Mol Sci
2022
23(6)
PubMed ID: 35328684
DOI: 10.3390/ijms23063264
|
|
20627
Soda T, Gen Y, Terasaki K, Iwai N, Kitaichi T, Dohi O, Taketani H, Seko Y, Umemura A, Nishikawa T, Yamaguchi K, Moriguchi M, Konishi H, Naito Y, Itoh Y, Yasui K.
Loss of KAP3 decreases intercellular adhesion and impairs intracellular transport of laminin in signet ring cell carcinoma of the stomach.
Sci Rep
2022
12(1):5050
PubMed ID: 35322078
DOI: 10.1038/s41598-022-08904-8
|
|
20661
Inoue H, Shiozaki A, Kosuga T, Shimizu H, Kudou M, Ohashi T, Arita T, Konishi H, Komatsu S, Kubota T, Fujiwara H, Okamoto K, Kishimoto M, Konishi E, Otsuji E.
Functions and Clinical Significance of CACNA2D1 in Gastric Cancer.
Ann Surg Oncol
2022
PubMed ID: 35445337
DOI: 10.1245/s10434-022-11752-5
|
|
21996
Fukami T, Shiozaki A, Kosuga T, Kudou M, Shimizu H, Ohashi T, Arita T, Konishi H, Komatsu S, Kubota T, Fujiwara H, Okamoto K, Kishimoto M, Morinaga Y, Konishi E, Otsuji E.
Anoctamin 5 regulates the cell cycle and affects prognosis in gastric cancer
World J Gastroenterol
2022
28(32):4649-4667.
PubMed ID: 36157935
DOI: 10.3748/wjg.v28.i32.4649
|
|
13323
Nishibeppu K, Komatsu S, Kiuchi J, Kishimoto T, Takashima Y, Shoda K, Arita T, Kosuga T, Konishi H, Shiozaki A, Kubota T, Okamoto K, Fujiwara H, Tsuda H, Otsuji E.
TRIM37 contributes to malignant outcomes and CDDP resistance in gastric cancer.
J Cancer
2021
PubMed ID: 33391428
DOI: 10.7150/jca.47577
|
|
20005
Iwata Y, Yasufuku I, Saigo C, Kito Y, Takeuchi T, Yoshida K.
Anti-fibrotic properties of an adiponectin paralog protein, C1q/TNF-related protein 6 (CTRP6), in diffuse gastric adenocarcinoma.
J Cancer
2021
12(4):1161-1168
PubMed ID: 33442414
DOI: 10.7150/jca.46765
|
|
20116
Kurashima K, Shiozaki A, Kudou M, Shimizu H, Arita T, Kosuga T, Konishi H, Komatsu S, Kubota T, Fujiwara H, Okamoto K, Kishimoto M, Konishi E, Otsuji E.
LRRC8A influences the growth of gastric cancer cells via the p53 signaling pathway.
Gastric Cancer
2021
PubMed ID: 33864161
DOI: 10.1007/s10120-021-01187-4
|
|
14345
Katsurahara K, Shiozaki A, Kosuga T, Shimizu H, Kudou M, Arita T, Konishi H, Komatsu S, Kubota T, Fujiwara H, Okamoto K, Kishimoto M, Konishi E, Otsuji E.
ANO9 regulates PD-L2 expression and binding ability to PD-1 in gastric cancer
Cancer Sci
2021
112(3):1026-1037.
PubMed ID: 33404124
DOI: 10.1111/cas.14796
|
|
16126
Nakamura K, Shiozaki A, Kosuga T, Shimizu H, Kudou M, Ohashi T, Arita T, Konishi H, Komatsu S, Kubota T, Fujiwara H, Okamoto K, Kishimoto M, Konishi E, Otsuji E.
The expression of the alpha1 subunit of Na +/K +-ATPase is related to tumor development and clinical outcomes in gastric cancer
Gastric Cancer
2021
24(6):1278-1292
PubMed ID: 34251542
DOI: 10.1007/s10120-021-01212-6
|
|
16229
Wenzhe Li, Atsushi Okabe, Genki Usui, Masaki Fukuyo, Keisuke Matsusaka, Bahityar Rahmutulla, Yasunobu Mano, Takayuki Hoshii, Sayaka Funata, Nobuhiro Hiura, Masashi Fukayama, Patrick Tan, Tetsuo Ushiku, Atsushi Kaneda
Activation of EHF via STAT3 phosphorylation by LMP2A in Epstein-Barr virus-positive gastric cancer
Cancer Sci
2021
112(8):3349-3362
PubMed ID: 34014591
DOI: 10.1111/cas.14978
|
|
16861
Kunzke T, Hölzl FT, Prade VM, Buck A, Huber K, Feuchtinger A, Ebert K, Zwingenberger G, Geffers R, Hauck SM, Haffner I, Luber B, Lordick F, Walch A.
Metabolomic therapy response prediction in pretherapeutic tissue biopsies for trastuzumab in patients with HER2-positive advanced gastric cancer
Clin Transl Med
2021
11(9):e547.
PubMed ID: 34586736
DOI: 10.1002/ctm2.547
|
|
12041
Hirano T, Shinsato Y, Tanabe K, Higa N, Kamil M, Kawahara K, Yamamoto M, Minami K, Shimokawa M, Arigami T, Yanagita S, Matushita D, Uenosono Y, Ishigami S, Kijima Y, Maemura K, Kitazono I, Tanimoto A, Furukawa T, Natsugoe S.
FARP1 boosts CDC42 activity from integrin αvβ5 signaling and correlates with poor prognosis of advanced gastric cancer.
Oncogenesis
2020
PubMed ID: 32029704
DOI: 10.1038/s41389-020-0190-7
|
|
13023
Berlamont H, De Witte C, Bauwens E, Min Jou H, Ducatelle R, De Meester E, Gansemans Y, Deforce D, Van Nieuwerburgh F, Haesebrouck F, Smet A.
Distinct transcriptome signatures of Helicobacter suis and Helicobacter heilmannii strains upon adherence to human gastric epithelial cells.
Vet Res
2020
PubMed ID: 32381076
DOI: 10.1186/s13567-020-00786-w
|
|
13131
Okabe A, Huang KK, Matsusaka K, Fukuyo M, Xing M, Ong X, Hoshii T, Usui G, Seki M, Mano Y, Rahmutulla B, Kanda T, Suzuki T, Rha SY, Ushiku T, Fukayama M, Tan P, Kaneda A.
Cross-species chromatin interactions drive transcriptional rewiring in Epstein-Barr virus-positive gastric adenocarcinoma.
Nat Genet
2020
PubMed ID: 32719515
DOI: 10.1038/s41588-020-0665-7
|
|
13315
Ebert K, Zwingenberger G, Barbaria E, Keller S, Heck C, Arnold R, Hollerieth V, Mattes J, Geffers R, Raimúndez E, Hasenauer J, Luber B.
Determining the effects of trastuzumab, cetuximab and afatinib by phosphoprotein, gene expression and phenotypic analysis in gastric cancer cell lines.
BMC Cancer
2020
PubMed ID: 33115415
DOI: 10.1186/s12885-020-07540-7
|
|
13344
Hinata M, Kunita A, Abe H, Morishita Y, Sakuma K, Yamashita H, Seto Y, Ushiku T, Fukayama M.
Exosomes of Epstein-Barr Virus-Associated Gastric Carcinoma Suppress Dendritic Cell Maturation.
Microorganisms
2020
PubMed ID: 33198173
DOI: 10.3390/microorganisms8111776
|
|
13504
Baatar S, Bai T, Yokobori T, Gombodorj N, Nakazawa N, Ubukata Y, Kimura A, Kogure N, Sano A, Sohda M, Sakai M, Tumenjargal A, Ogata K, Kuwano H, Shirabe K, Saeki H.
High RAD18 Expression is Associated with Disease Progression and Poor Prognosis in Patients with Gastric Cancer
Ann Surg Oncol
2020
27(11):4360-4368
PubMed ID: 32356270
DOI: 10.1245/s10434-020-08518-2
|
|
13525
Asakawa Y, Okabe A, Fukuyo M, Li W, Ikeda E, Mano Y, Funata S, Namba H, Fujii T, Kita K, Matsusaka K, Kaneda A.
Epstein-Barr virus-positive gastric cancer involves enhancer activation through activating transcription factor 3
Cancer Sci
2020
111(5):1818-1828
PubMed ID: 32119176
DOI: 10.1111/cas.14370
|
|
13600
Sano H, Futamura M, Gaowa S, Kamino H, Nakamura Y, Yamaguchi K, Tanaka Y, Yasufuku I, Nakakami A, Arakawa H, Yoshida K.
p53/Mieap-regulated mitochondrial quality control plays an important role as a tumor suppressor in gastric and esophageal cancers
Biochem Biophys Res Commun
2020
529(3):582-589.
PubMed ID: 32736677
DOI: 10.1016/j.bbrc.2020.05.168
|
|
14832
Saito S, Kitamura-Muramatsu Y, Komine F, Polat M, Takeshima SN, Takei M, Aida Y.
Absence of bovine leukemia virus proviral DNA in Japanese human blood cell lines and human cancer cell lines
Arch Virol
2020
165(1):207-214
PubMed ID: 31776677
DOI: 10.1007/s00705-019-04474-9
|
|
11505
Kageyama-Yahara N, Yamamichi N, Takahashi Y, Takeuchi C, Matsumoto Y, Sakaguchi Y, Koike K.
Tandem repeats of the 5' flanking region of human MUC5AC have a role as a novel enhancer in MUC5AC gene expression.
Biochem Biophys Rep
2019
18:100632
PubMed ID: 30993217
DOI: 10.1016/j.bbrep.2019.100632
|
|
11568
De Witte C, Demeyere K, De Bruyckere S, Taminiau B, Daube G, Ducatelle R, Meyer E, Haesebrouck F.
Characterization of the non-glandular gastric region microbiota in Helicobacter suis-infected versus non-infected pigs identifies a potential role for Fusobacterium gastrosuis in gastric ulceration.
Vet. Res.
2019
50(1):39
PubMed ID: 31126330
DOI: 10.1186/s13567-019-0656-9
|
|
11499
S Zhang et al
Sensitization of Gastric Cancer Cells to Irinotecan by p53 Activation
BPB Reports
2019
2,130-133
|
|
14935
Wu D, Yan J, Shen X, Sun Y, Thulin M, Cai Y, Wik L, Shen Q, Oelrich J, Qian X, Dubois KL, Ronquist KG, Nilsson M, Landegren U, Kamali-Moghaddam M.
Profiling surface proteins on individual exosomes using a proximity barcoding assay
Nat Commun
2019
10(1):3854
PubMed ID: 31451692
DOI: 10.1038/s41467-019-11486-1
|
|
10787
Shimada S, Akiyama Y, Mogushi K, Ishigami-Yuasa M, Kagechika H, Nagasaki H, Fukamachi H, Yuasa Y, Tanaka S.
Identification of selective inhibitors for diffuse-type gastric cancer cells by screening of annotated compounds in preclinical models.
Br. J. Cancer
2018
118:972-984
PubMed ID: 29527007
DOI: 10.1038/s41416-018-0008-y
|
|
11145
Li W, Wong CC, Zhang X, Kang W, Nakatsu G, Zhao Q, Chen H, Go MYY, Chiu PWY, Wang X, Ji J, Li X, Cai Z, Ng EKW, Yu J.
CAB39L elicited an anti-Warburg effect via a LKB1-AMPK-PGC1α axis to inhibit gastric tumorigenesis.
Oncogene
2018
37(50):6383-6398
PubMed ID: 30054562
DOI: 10.1038/s41388-018-0402-1
|
|
11095
Kim M, Pyo S, Kang CH, Lee CO, Lee HK, Choi SU, Park CH.
Folate receptor 1 (FOLR1) targeted chimeric antigen receptor (CAR) T cells for the treatment of gastric cancer.
PLoS ONE
2018
13(6):e0198347
PubMed ID: 29874279
DOI: 10.1371/journal.pone.0198347
|
|
11231
Wang Z, Qu H, Gong W, Liu A.
Up-regulation and tumor-promoting role of SPHK1 were attenuated by miR-330-3p in gastric cancer.
IUBMB Life
2018
PubMed ID: 30281914
DOI: 10.1002/iub.1934
|
|
4300
Keller S, Zwingenberger G, Ebert K, Hasenauer J, Wasmuth J, Maier D, Haffner I, Schierle K, Weirich G, Luber B.
Effects of trastuzumab and afatinib on kinase activity in gastric cancer cell lines.
Mol Oncol
2018
PubMed ID: 29325228
DOI: 10.1002/1878-0261.12170
|
|
4313
Kiuchi J, Komatsu S, Imamura T, Nishibeppu K, Shoda K, Arita T, Kosuga T, Konishi H, Shiozaki A, Kubota T, Okamoto K, Fujiwara H, Ichikawa D, Tsuda H, Otsuji E.
Overexpression of YEATS4 contributes to malignant outcomes in gastric carcinoma.
Am J Cancer Res
2018
PubMed ID: 30662802
|
|
4380
Yoshioka T, Shien K, Namba K, Torigoe H, Sato H, Tomida S, Yamamoto H, Asano H, Soh J, Tsukuda K, Nagasaka T, Fujiwara T, Toyooka S.
Antitumor activity of pan-HER inhibitors in HER2-positive gastric cancer.
Cancer Sci.
2018
109(4):1166-1176
PubMed ID: 29465762
DOI: 10.1111/cas.13546
|
|
9788
Deguchi Y, Okabe H, Oshima N, Hisamori S, Minamiguchi S, Muto M, Sakai Y.
PTEN loss is associated with a poor response to trastuzumab in HER2-overexpressing gastroesophageal adenocarcinoma.
Gastric Cancer
2017
20:416-427
PubMed ID: 27517839
DOI: 10.1007/s10120-016-0627-z
|
|
9945
Ooi A, Oyama T, Nakamura R, Tajiri R, Ikeda H, Fushida S, Dobashi Y.
Gene amplification of CCNE1, CCND1, and CDK6 in gastric cancers detected by multiplex ligation-dependent probe amplification and fluorescence in situ hybridization.
Hum. Pathol.
2017
61:58-67
PubMed ID: 27864121
DOI: 10.1016/j.humpath.2016.10.025
|
|
9978
Kneissl J, Hartmann A, Pfarr N, Erlmeier F, Lorber T, Keller S, Zwingenberger G, Weichert W, Luber B.
Influence of the HER receptor ligand system on sensitivity to cetuximab and trastuzumab in gastric cancer cell lines.
J. Cancer Res. Clin. Oncol.
2017
143:573-600
PubMed ID: 27933395
DOI: 10.1007/s00432-016-2308-z
|
|
10134
Qian Y, Wong CC, Xu J, Chen H, Zhang Y, Kang W, Wang H, Zhang L, Li W, Chu ESH, Go MYY, Chiu PWY, Ng EKW, Chan FKL, Sung JJY, Si J, Yu J.
Sodium Channel Subunit SCNN1B Suppresses Gastric Cancer Growth and Metastasis via GRP78 Degradation.
Cancer Res.
2017
77:1968-1982
PubMed ID: 28202509
DOI: 10.1158/0008-5472.CAN-16-1595
|
|
10258
Gen Y, Yasui K, Kitaichi T, Iwai N, Terasaki K, Dohi O, Hashimoto H, Fukui H, Inada Y, Fukui A, Jo M, Moriguchi M, Nishikawa T, Umemura A, Yamaguchi K, Konishi H, Naito Y, Itoh Y.
ASPP2 suppresses invasion and TGF-β1-induced epithelial-mesenchymal transition by inhibiting Smad7 degradation mediated by E3 ubiquitin ligase ITCH in gastric cancer.
Cancer Lett.
2017
398:52-61
PubMed ID: 28400336
DOI: 10.1016/j.canlet.2017.04.002
|
|
10437
Yanoma T, Ogata K, Yokobori T, Ide M, Mochiki E, Toyomasu Y, Yanai M, Kogure N, Kimura A, Suzuki M, Nakazawa N, Bai T, Oyama T, Asao T, Shirabe K, Kuwano H.
Heat shock-induced HIKESHI protects cell viability via nuclear translocation of heat shock protein 70.
Oncol. Rep.
2017
38:1500-1506
PubMed ID: 28731175
DOI: 10.3892/or.2017.5844
|
|
10460
Li HK, Morokoshi Y, Nagatsu K, Kamada T, Hasegawa S.
Locoregional therapy with α-emitting trastuzumab against peritoneal metastasis of human epidermal growth factor receptor 2-positive gastric cancer in mice.
Cancer Sci.
2017
108:1648-1656
PubMed ID: 28514062
DOI: 10.1111/cas.13282
|
|
10586
Ishii S, Yamashita K, Harada H, Ushiku H, Tanaka T, Nishizawa N, Yokoi K, Washio M, Ema A, Mieno H, Moriya H, Hosoda K, Waraya M, Katoh H, Watanabe M.
The H19-PEG10/IGF2BP3 axis promotes gastric cancer progression in patients with high lymph node ratios.
Oncotarget
2017
8:74567-74581
PubMed ID: 29088808
DOI: 10.18632/oncotarget.20209
|
|
5806
Shiroki T et al
Enhanced expression of the M2 isoform of pyruvate kinase is involved in gastric cancer development by regulating cancer-specific metabolism.
Cancer Sci
2017
108(5):931-940
PubMed ID: 28235245
DOI: 10.1111/cas.13211
|
|
14227
Okabe A, Funata S, Matsusaka K, Namba H, Fukuyo M, Rahmutulla B, Oshima M, Iwama A, Fukayama M, Kaneda A.
Regulation of tumour related genes by dynamic epigenetic alteration at enhancer regions in gastric epithelial cells infected by Epstein-Barr virus
Sci Rep
2017
7(1):7924
PubMed ID: 28801683
DOI: 10.1038/s41598-017-08370-7
|
|
14615
Nambara S, Masuda T, Nishio M, Kuramitsu S, Tobo T, Ogawa Y, Hu Q, Iguchi T, Kuroda Y, Ito S, Eguchi H, Sugimachi K, Saeki H, Oki E, Maehara Y, Suzuki A, Mimori K.
Antitumor effects of the antiparasitic agent ivermectin via inhibition of Yes-associated protein 1 expression in gastric cancer
Oncotarget
2017
8(64):107666-107677
PubMed ID: 29296196
DOI: 10.18632/oncotarget.22587
|
|
14631
Funata S, Matsusaka K, Yamanaka R, Yamamoto S, Okabe A, Fukuyo M, Aburatani H, Fukayama M, Kaneda A.
Histone modification alteration coordinated with acquisition of promoter DNA methylation during Epstein-Barr virus infection
Oncotarget
2017
8(33):55265-55279
PubMed ID: 28903418
DOI: 10.18632/oncotarget.19423
|
|
14663
Ito M, Migita K, Matsumoto S, Wakatsuki K, Tanaka T, Kunishige T, Nakade H, Nakatani M, Nakajima Y.
Overexpression of E3 ubiquitin ligase tripartite motif 32 correlates with a poor prognosis in patients with gastric cancer
Oncol Lett
2017
13(5):3131-3138
PubMed ID: 28521418
DOI: 10.3892/ol.2017.5806
|
|
14737
Baba K, Kitajima Y, Miyake S, Nakamura J, Wakiyama K, Sato H, Okuyama K, Kitagawa H, Tanaka T, Hiraki M, Yanagihara K, Noshiro H.
Hypoxia-induced ANGPTL4 sustains tumour growth and anoikis resistance through different mechanisms in scirrhous gastric cancer cell lines
Sci Rep
2017
7(1):11127
PubMed ID: 28894280
DOI: 10.1038/s41598-017-11769-x
|
|
7159
Joosten M, Linden S, Rossi M, Tay AC, Skoog E, Padra M, Peters F, Perkins T, Vandamme P, Van Nieuwerburgh F, D'Herde K, Van den Broeck W, Flahou B, Deforce D, Ducatelle R, Marshall B, Haesebrouck F, Smet A.
Divergence between the Highly Virulent Zoonotic Pathogen Helicobacter heilmannii and Its Closest Relative, the Low-Virulence "Helicobacter ailurogastricus" sp. nov.
Infect. Immun.
2016
84:293-306
PubMed ID: 26527212
DOI: 10.1128/IAI.01300-15
|
|
9606
Cheng L, Mirko R, Sara L, Medea P, Caroline B, Eva B, Myrthe J, Bram F, Wim VD, Richard D, Freddy H, Annemieke S.
The Helicobacter heilmannii hofE and hofF Genes are Essential for Colonization of the Gastric Mucosa and Play a Role in IL-1β-Induced Gastric MUC13 Expression.
Helicobacter
2016
21:504-522
PubMed ID: 26935145
DOI: 10.1111/hel.12307
|
|
9610
Saju P, Murata-Kamiya N, Hayashi T, Senda Y, Nagase L, Noda S, Matsusaka K, Funata S, Kunita A, Urabe M, Seto Y, Fukayama M, Kaneda A, Hatakeyama M.
Host SHP1 phosphatase antagonizes Helicobacter pylori CagA and can be downregulated by Epstein-Barr virus.
Nat Microbiol
2016
1:16026
PubMed ID: 27572445
DOI: 10.1038/nmicrobiol.2016.26
|
|
9928
Diaz-Lagares A, Crujeiras AB, Lopez-Serra P, Soler M, Setien F, Goyal A, Sandoval J, Hashimoto Y, Martinez-Cardús A, Gomez A, Heyn H, Moutinho C, Espada J, Vidal A, Paúles M, Galán M, Sala N, Akiyama Y, Martínez-Iniesta M, Farré L, Villanueva A, Gross M, Diederichs S, Guil S, Esteller M.
Epigenetic inactivation of the p53-induced long noncoding RNA TP53 target 1 in human cancer.
Proc. Natl. Acad. Sci. U.S.A.
2016
113:E7535-E7544
PubMed ID: 27821766
DOI: 10.1073/pnas.1608585113
|
|
10867
P. Li, Chenghong Wang, Sen Guo, Z. Zhang
Neuropilin 2 could promote gastric adenocarcinoma lymphatic invasionwith VEGF-C stimulation
Int J Clin Exp Med
2016
9:2795-2803
|
|
3733
Nishikawaji T, Akiyama Y, Shimada S, Kojima K, Kawano T, Eishi Y, Yuasa Y, Tanaka S.
Oncogenic roles of the SETDB2 histone methyltransferase in gastric cancer.
Oncotarget
2016
7(41):67251-67265
PubMed ID: 27572307
DOI: 10.18632/oncotarget.11625
|
|
12613
Takeda S, Tanigawa T, Watanabe T, Tatsuwaki H, Nadatani Y, Otani K, Nagami Y, Tanaka F, Kamata N, Yamagami H, Shiba M, Tominaga K, Fujiwara Y, Muguruma K, Ohira M, Hirakawa K, Arakawa T.
Reduction of prostaglandin transporter predicts poor prognosis associated with angiogenesis in gastric adenocarcinoma
J Gastroenterol Hepatol
2016
31(2):376-83
PubMed ID: 26250887
DOI: 10.1111/jgh.13079
|
|
12873
Liu X, Kwong A, Sihoe A, Chu KM.
Plasma miR-940 may serve as a novel biomarker for gastric cancer
Tumour Biol
2016
37(3):3589-97
PubMed ID: 26456959
DOI: 10.1007/s13277-015-4019-5
|
|
12874
Altan B, Yokobori T, Ide M, Mochiki E, Toyomasu Y, Kogure N, Kimura A, Hara K, Bai T, Bao P, Suzuki M, Ogata K, Asao T, Nishiyama M, Oyama T, Kuwano H.
Nuclear PRMT1 expression is associated with poor prognosis and chemosensitivity in gastric cancer patients
Gastric Cancer
2016
19(3):789-97.
PubMed ID: 26472729
DOI: 10.1007/s10120-015-0551-7
|
|
12891
Namba-Fukuyo H, Funata S, Matsusaka K, Fukuyo M, Rahmutulla B, Mano Y, Fukayama M, Aburatani H, Kaneda A.
TET2 functions as a resistance factor against DNA methylation acquisition during Epstein-Barr virus infection
Oncotarget
2016
7(49):81512-81526.
PubMed ID: 27829228
DOI: 10.18632/oncotarget.13130
|
|
12951
Kubo H, Kitajima Y, Kai K, Nakamura J, Miyake S, Yanagihara K, Morito K, Tanaka T, Shida M, Noshiro H.
Regulation and clinical significance of the hypoxia-induced expression of ANGPTL4 in gastric cancer
Oncol Lett
2016
11(2):1026-1034.
PubMed ID: 26893686
DOI: 10.3892/ol.2015.4011
|
|
12968
Kimura A, Ogata K, Altan B, Yokobori T, Ide M, Mochiki E, Toyomasu Y, Kogure N, Yanoma T, Suzuki M, Bai T, Oyama T, Kuwano H.
Nuclear heat shock protein 110 expression is associated with poor prognosis and chemotherapy resistance in gastric cancer
Oncotarget
2016
7(14):18415-23
PubMed ID: 26943774
DOI: 10.18632/oncotarget.7821
|
|
7470
Sakimura S, Sugimachi K, Kurashige J, Ueda M, Hirata H, Nambara S, Komatsu H, Saito T, Takano Y, Uchi R, Sakimura E, Shinden Y, Iguchi T, Eguchi H, Oba Y, Hoka S, Mimori K.
The miR-506-Induced Epithelial-Mesenchymal Transition is Involved in Poor Prognosis for Patients with Gastric Cancer.
Ann. Surg. Oncol.
2015
22 Suppl 3:S1436-43
PubMed ID: 25707493
DOI: 10.1245/s10434-015-4418-2
|
|
5817
Sun Q, Lin P, Zhang J, Li X, Yang L, Huang J, Zhou Z, Liu P, Liu N.
Expression of Fibroblast Growth Factor 10 Is Correlated with Poor Prognosis in Gastric Adenocarcinoma.
Tohoku J Exp Med
2015
236(4):311-8
PubMed ID: 26268776
DOI: 10.1620/tjem.236.311
|
|
5819
Yoshida K, Tsujimoto H, Matsumura K, Kinoshita M, Takahata R, Matsumoto Y, Hiraki S, Ono S, Seki S, Yamamoto J, Hase K.
CD47 is an adverse prognostic factor and a therapeutic target in gastric cancer.
Cancer Med
2015
4(9):1322-33
PubMed ID: 26077800
DOI: 10.1002/cam4.478
|
|
14961
Angiopoietin-like protein 2 is a potential biomarker for gastric cancer
Angiopoietin-like protein 2 is a potential biomarker for gastric cancer
Molecular Medicine Reports
2015
11:2653-2658
PubMed ID: 25484242
DOI: 10.3892/mmr.2014.3040
|
|
15000
Sakamoto A, Akiyama Y, Shimada S, Zhu WG, Yuasa Y, Tanaka S.
DNA Methylation in the Exon 1 Region and Complex Regulation of Twist1 Expression in Gastric Cancer Cells
PLoS One
2015
10(12):e0145630
PubMed ID: 26695186
DOI: 10.1371/journal.pone.0145630
|
|
15037
Toiyama Y, Tanaka K, Kitajima T, Shimura T, Imaoka H, Mori K, Okigami M, Yasuda H, Okugawa Y, Saigusa S, Ohi M, Inoue Y, Mohri Y, Goel A, Kusunoki M.
Serum angiopoietin-like protein 2 as a potential biomarker for diagnosis, early recurrence and prognosis in gastric cancer patients
Carcinogenesis
2015
36(12):1474-83
PubMed ID: 26420253
DOI: 10.1093/carcin/bgv139
|
|
15073
Banerjee D, Fernandez HR, Patil PB, Premaratne P, Quiding-Järbrink M, Lindén SK.
Epithelial MUC1 promotes cell migration, reduces apoptosis and affects levels of mucosal modulators during acetylsalicylic acid (aspirin)-induced gastropathy
Biochem J
2015
465(3):423-31
PubMed ID: 25387004
DOI: 10.1042/BJ20140617
|
|
18932
Kang W, Tong JH, Chan AW, Zhao J, Dong Y, Wang S, Yang W, Sin FM, Ng SS, Yu J, Cheng AS, To KF.
Yin Yang 1 contributes to gastric carcinogenesis and its nuclear expression correlates with shorter survival in patients with early stage gastric adenocarcinoma
J Transl Med
2014
12:80
PubMed ID: 24674326
DOI: 10.1186/1479-5876-12-80
|
|
5826
Zhu DY, Guo QS, Li YL, Cui B, Guo J, Liu JX, Li P.
Twist1 correlates with poor differentiation and progression in gastric adenocarcinoma via elevation of FGFR2 expression.
World J Gastroenterol
2014
28;20(48):18306-15
PubMed ID: 25561797
DOI: 10.3748/wjg.v20.i48.18306
|
|
5827
Ito T, Kajino K, Abe M, Sato K, Maekawa H, Sakurada M, Orita H, Wada R, Kajiyama Y, Hino O.
ERC/mesothelin is expressed in human gastric cancer tissues and cell lines.
Oncol Rep
2014
31(1):27-33
PubMed ID: 24146039
DOI: 10.3892/or.2013.2803
|
|
19058
Tanaka T, Nakamura J, Kitajima Y, Kai K, Miyake S, Hiraki M, Ide T, Koga Y, Noshiro H.
Loss of trefoil factor 1 is regulated by DNA methylation and is an independent predictive factor for poor survival in advanced gastric cancer
Int J Oncol
2013
42(3):894-902
PubMed ID: 23291975
DOI: 10.3892/ijo.2013.1759
|
|
5840
Kawada M, Inoue H, Ohba S, Hatano M, Amemiya M, Hayashi C, Usami I, Abe H, Watanabe T, Kinoshita N, Igarashi M, Masuda T, Ikeda D, Nomoto
Intervenolin, a new antitumor compound with anti-Helicobacter pylori activity, from Nocardia sp. ML96-86F2.
J Antibiot (Tokyo)
2013
66(9):543-8
PubMed ID: 23632919
DOI: 10.1038/ja.2013.42
|
|
5845
Konno-Shimizu M1, Yamamichi N, Inada K, Kageyama-Yahara N, Shiogama K, Takahashi Y, Asada-Hirayama I, Yamamichi-Nishina M, Nakayama C, Ono S, Kodashima S, Fujishiro M, Tsutsumi Y, Ichinose M, Koike K.
Cathepsin E is a marker of gastric differentiation and signet-ring cell carcinoma of stomach: a novel suggestion on gastric tumorigenesis.
PLoS One
2013
8(2):e56766
PubMed ID: 23451082
DOI: 10.1371/journal.pone.0056766
|
|
14202
Navabi N, McGuckin MA, Lindén SK.
Gastrointestinal cell lines form polarized epithelia with an adherent mucus layer when cultured in semi-wet interfaces with mechanical stimulation
PLoS One
2013
8(7):e68761
PubMed ID: 23869232
DOI: 10.1371/journal.pone.0068761
|
|
5848
Kataoka Y, Mukohara T, Tomioka H, Funakoshi Y, Kiyota N, Fujiwara Y, Yashiro M, Hirakawa K, Hirai M, Minami H.
Foretinib (GSK1363089), a multi-kinase inhibitor of MET and VEGFRs, inhibits growth of gastric cancer cell lines by blocking inter-receptor tyrosine kinase networks.
Invest New Drugs
2012
30(4):1352-60
PubMed ID: 21655918
DOI: 10.1007/s10637-011-9699-0
|
|
5852
Tomioka H, Mukohara T, Kataoka Y, Ekyalongo RC, Funakoshi Y, Imai Y, Kiyota N, Fujiwara Y, Minami H.
Inhibition of the mTOR/S6K signal is necessary to enhance fluorouracil-induced apoptosis in gastric cancer cells with HER2 amplification.
Int J Oncol
2012
41(2):551-8
PubMed ID: 22614071
DOI: 10.3892/ijo.2012.1485
|
|
5855
Yang Y, Toy W, Choong LY, Hou P, Ashktorab H, Smoot DT, Yeoh KG, Lim YP.
Discovery of SLC3A2 cell membrane protein as a potential gastric cancer biomarker: implications in molecular imaging.
J Proteome Res
2012
11(12):5736-47
PubMed ID: 23116296
DOI: 10.1021/pr300555y
|
|
15746
Hayakawa Y, Hirata Y, Sakitani K, Nakagawa H, Nakata W, Kinoshita H, Takahashi R, Takeda K, Ichijo H, Maeda S, Koike K.
Apoptosis signal-regulating kinase-1 inhibitor as a potent therapeutic drug for the treatment of gastric cancer
Cancer Sci
2012
103:2181-5
PubMed ID: 23110662
DOI: 10.1111/cas.12024
|
|
7876
Hiraki M, Kitajima Y, Koga Y, Tanaka T, Nakamura J, Hashiguchi K, Noshiro H, Miyazaki K.
Aberrant gene methylation is a biomarker for the detection of cancer cells in peritoneal wash samples from advanced gastric cancer patients.
Ann. Surg. Oncol.
2011
18:3013-9
PubMed ID: 21409489
DOI: 10.1245/s10434-011-1636-0
|
|
7990
Aoki M, Ishigami S, Uenosono Y, Arigami T, Uchikado Y, Kita Y, Kurahara H, Matsumoto M, Ueno S, Natsugoe S.
Expression of BMP-7 in human gastric cancer and its clinical significance.
Br. J. Cancer
2011
104:714-8
PubMed ID: 21224856
DOI: 10.1038/sj.bjc.6606075
|
|
8253
Seto M, Ohta M, Ikenoue T, Sugimoto T, Asaoka Y, Tada M, Mohri D, Kudo Y, Ijichi H, Tateishi K, Otsuka M, Hirata Y, Maeda S, Koike K, Omata M.
Reduced expression of RAS protein activator like-1 in gastric cancer.
Int. J. Cancer
2011
128:1293-302
PubMed ID: 20473946
DOI: 10.1002/ijc.25459
|
|
5865
Nakata W, Hayakawa Y, Nakagawa H, Sakamoto K, Kinoshita H, Takahashi R, Hirata Y, Maeda S, Koike K.
Anti-tumor activity of the proteasome inhibitor bortezomib in gastric cancer.
Int J Oncol
2011
39(6):1529-36
PubMed ID: 21785822
DOI: 10.3892/ijo.2011.1141
|
|
5866
Nakamura J, Kitajima Y, Kai K, Hashiguchi K, Hiraki M, Noshiro H, Miyazaki K.
Expression of hypoxic marker CA IX is regulated by site-specific DNA methylation and is associated with the histology of gastric cancer.
Am J Pathol
2011
178(2):515-24
PubMed ID: 21281785
DOI: 10.1016/j.ajpath.2010.10.010
|
|
6115
Kakimoto T, Shiraishi R, Iwakiri R, Fujimoto K, Takahashi H, Hamajima H, Mizuta T, Ideguchi H, Toda S, Kitajima Y, Ozaki I, Matsuhashi S.
Expression patterns of the tumor suppressor PDCD4 and correlation with β-catenin expression in gastric cancers.
Oncol Rep
2011
26(6):1385-92
PubMed ID: 21894439
DOI: 10.3892/or.2011.1450
|
|
16164
Masateru Maruyama, Hiroki Odagiri, Shojiro-Kazunori Ikenaga, Tatsuya Nodagashira, Toshiyuki Sato, Kenichi Hakamada, Hirofumi Munakata
The suicide gene introduction using two recombinant adenovirus vectors with HER2 promoter and Cre/loxP system
Hirosaki Medical Journal
2011
61:150-158
DOI: 10.32216/hirosakiigaku.61.2-4_150
|
|
16560
Matsusaka K, Kaneda A, Nagae G, Ushiku T, Kikuchi Y, Hino R, Uozaki H, Seto Y, Takada K, Aburatani H, Fukayama M.
Classification of Epstein-Barr virus-positive gastric cancers by definition of DNA methylation epigenotypes
Cancer Res
2011
71(23):7187-97.
PubMed ID: 21990320
DOI: 10.1158/0008-5472.CAN-11-1349
|
|
18757
Kawaguchi K, Etoh T, Suzuki K, Mitui MT, Nishizono A, Shiraishi N, Kitano S.
Efficacy of oncolytic reovirus against human gastric cancer with peritoneal metastasis in experimental animal model
Int J Oncol
2010
37(6):1433-8
PubMed ID: 21042711
DOI: 10.3892/ijo_00000795
|
|
5884
Lindén SK, Sheng YH, Every AL, Miles KM, Skoog EC, Florin TH, Sutton P, McGuckin MA.
MUC1 limits Helicobacter pylori infection both by steric hindrance and by acting as a releasable decoy.
PLoS Pathog
2009
5(10):e1000617
PubMed ID: 19816567
DOI: 10.1371/journal.ppat.1000617
|
|
6410
Danjoh I, Sone H, Noda N, Iimura E, Nagayoshi M, Saijo K, Hiroyama T, Nakamura Y.
Is parainfluenza virus a threatening virus for human cancer cell lines?
Hum Cell
2009
22(3):81-4
PubMed ID: 19624309
DOI: 10.1111/j.1749-0774.2009.00071.x
|
|
18978
Yamauchi K, Choi IJ, Lu H, Ogiwara H, Graham DY, Yamaoka Y.
Regulation of IL-18 in Helicobacter pylori infection
J Immunol
2008
180(2):1207-16
PubMed ID: 18178861
DOI: 10.4049/jimmunol.180.2.1207
|
|
6139
Jin SH, Akiyama Y, Fukamachi H, Yanagihara K, Akashi T, Yuasa Y.
IQGAP2 inactivation through aberrant promoter methylation and promotion of invasion in gastric cancer cells.
Int J Cancer
2008
122(5):1040-6
PubMed ID: 17957782
DOI: 10.1002/ijc.23181
|
|
12803
Lindén SK, Driessen KM, McGuckin MA.
Improved in vitro model systems for gastrointestinal infection by choice of cell line, pH, microaerobic conditions, and optimization of culture conditions
Helicobacter
2007
12(4):341-53
PubMed ID: 17669108
DOI: 10.1111/j.1523-5378.2007.00509.x
|
|
18965
Koga Y, Kitajima Y, Miyoshi A, Sato K, Sato S, Miyazaki K.
The significance of aberrant CHFR methylation for clinical response to microtubule inhibitors in gastric cancer
J Gastroenterol
2006
41(2):133-9
PubMed ID: 16568372
DOI: 10.1007/s00535-005-1732-7
|
|
3332
Kanehara, Isao, Nakata, Bunzo, Hirakawa, Kosei
Caspase-8 is scarcely silenced and its activity is well correlated with the anticancer effect of tumor necrosis factor-related apoptosis-inducing ligand in gastric cancer cells.
Oncol Rep
2005
14:1249-53
PubMed ID: 16211292
DOI: 10.3892/or.14.5.1249
|
|
3109
Honjo, Soichiro, Osaki, Mitsuhiko, Ardyanto, Tonang Dwi, Hiramatsu, Toshiki, Maeta, Noritaka, Ito, Hisao
COX-2 inhibitor, NS398, enhances Fas-mediated apoptosis via modulation of the PTEN-Akt pathway in human gastric carcinoma cell lines.
DNA Cell Biol
2005
24:141-7
PubMed ID: 15767780
DOI: 10.1089/dna.2005.24.141
|
|
3375
Ohta M, Tateishi K, Kanai F, Watabe H, Kondo S, Guleng B, Tanaka Y, Asaoka Y, Jazag A, Imamura J, Ijichi H, Ikenoue T, Sata M, Miyagishi M, Taira K, Tada M, Kawabe T, Omata M.
p53-Independent negative regulation of p21/cyclin-dependent kinase-interacting protein 1 by the sonic hedgehog-glioma-associated oncogene 1 pathway in gastric carcinoma cells.
Cancer Res.
2005
65:10822-9
PubMed ID: 16322228
DOI: 10.1158/0008-5472.CAN-05-0777
|
|
5918
Ono HA, Davydova JG, Adachi Y, Takayama K, Barker SD, Reynolds PN, Krasnykh VN, Kunisaki C, Shimada H, Curiel DT, Yamamoto M.
Promoter-controlled infectivity-enhanced conditionally replicative adenoviral vectors for the treatment of gastric cancer.
J Gastroenterol
2005
40(1):31-42
PubMed ID: 15692787
DOI: 10.1007/s00535-004-1490-y
|
|
12834
Lu H, Wu JY, Kudo T, Ohno T, Graham DY, Yamaoka Y.
Regulation of interleukin-6 promoter activation in gastric epithelial cells infected with Helicobacter pylori
Mol Biol Cell
2005
16(10):4954-66.
PubMed ID: 16030249
DOI: 10.1091/mbc.e05-05-0426
|
|
2921
Ishihara, Shunji, Rumi, Mohammad Azharul Karim, Kadowaki, Yasunori, Ortega-Cava, Cesar Francisco, Yuki, Takafumi, Yoshino, Nagisa, Miyaoka, Youichi, Kazumori, Hideaki, Ishimura, Norihisa, Amano, Yuji, Kinoshita, Yoshikazu
Essential role of MD-2 in TLR4-dependent signaling during Helicobacter pylori-associated gastritis.
J Immunol
2004
173:1406-16
PubMed ID: 15240737
DOI: 10.4049/jimmunol.173.2.1406
|
|
3105
Osaki M, Moriyama M, Adachi K, Nakada C, Takeda A, Inoue Y, Adachi H, Sato K, Oshimura M, Ito H
Expression of RUNX3 protein in human gastric mucosa, intestinal metaplasia and carcinoma.
Eur J Clin Invest
2004
34:605-12
PubMed ID: 15379759
DOI: 10.1111/j.1365-2362.2004.01401.x
|
|
5922
Meng H, Lu C, Mabuchi H, Tanigawa N.
Prognostic significance and different properties of survivin splicing variants in gastric cancer.
Cancer Lett
2004
216(2):147-55
PubMed ID: 15533590
DOI: 10.1016/j.canlet.2003.12.020
|
|
5923
Namiki Y, Namiki T, Date M, Yanagihara K, Yashiro M, Takahashi H.
Enhanced photodynamic antitumor effect on gastric cancer by a novel photosensitive stealth liposome.
Pharmacol Res.
2004
50(1):65-76
PubMed ID: 15082031
DOI: 10.1016/j.phrs.2003.12.015
|
|
5928
Kawashima R, Haisa M, Kimura M, Takaoka M, Shirakawa Y, Takeda H, Uetsuka H, Gunduz M, Nagai N, Tanaka N, Naomoto Y.
Cyclin A correlates with the sensitivity of human cancer cells to cytotoxic effects of 5-FU.
Int J Oncolo
2004
24(2):273-8
PubMed ID: 14719102
|
|
3103
Adachi, Keiko, Osaki, Mitsuhiko, Kase, Satoru, Takeda, Ami, Ito, Hisao
Anti-Fas antibody-induced apoptosis and its signal transduction in human gastric carcinoma cell lines.
Int J Oncol
2003
23:713-9
PubMed ID: 12888908
|
|
18968
Akiyama Y, Maesawa C, Ogasawara S, Terashima M, Masuda T.
Cell-type-specific repression of the maspin gene is disrupted frequently by demethylation at the promoter region in gastric intestinal metaplasia and cancer cells
Am J Pathol
2003
163(5):1911-9
PubMed ID: 14578190
DOI: 10.1016/S0002-9440(10)63549-3
|
|
3796
Fukami T, Fukuhara H, Kuramochi M, Maruyama T, Isogai K, Sakamoto M, Takamoto S, Murakami Y.
Promoter methylation of the TSLC1 gene in advanced lung tumors and various cancer cell lines.
Int J Cancer
2003
107(1):53-9
PubMed ID: 12925956
DOI: 10.1002/ijc.11348
|
|
5936
Terashima M, Irinoda T, Kawamura H, Takagane A, Abe K, Oyama K, Fujiwara H, Saito K, Gotoh M, Shirasaka T.
Intermittent FLDP: 24-h infusion of 5-FU on days 1, 3 and 5 combined with low-dose cisplatin on days 1-5 for gastric cancer, and its pharmacologic and kinetic rationale.
Cancer Chemother Pharmacol
2003
51(3):240-6
PubMed ID: 12655443
DOI: 10.1007/s00280-003-0568-1
|
|
17305
Jawhari AU, Buda A, Jenkins M, Shehzad K, Sarraf C, Noda M, Farthing MJ, Pignatelli M, Adams JC.
Fascin, an actin-bundling protein, modulates colonic epithelial cell invasiveness and differentiation in vitro
Am J Pathol
2003
162(1):69-80
PubMed ID: 12507891
DOI: 10.1016/S0002-9440(10)63799-6
|
|
5939
Okuyama T, Ishihara S, Sato H, Rumi MA, Kawashima K, Miyaoka Y, Suetsugu H, Kazumori H, Cava CF, Kadowaki Y, Fukuda R, Kinoshita Y.
Activation of prostaglandin E2-receptor EP2 and EP4 pathways induces growth inhibition in human gastric carcinoma cell lines.
J Lab Clin Med
2002
140(2):92-102
PubMed ID: 12228765
DOI: 10.1067/mlc.2002.125784
|
|
5940
Chong JM, Sakuma K, Sudo M, Osawa T, Ohara E, Uozaki H, Shibahara J, Kuroiwa K, Tominaga S, Hippo Y, Aburatani H, Funata N, Fukayama M.
Interleukin-1beta expression in human gastric carcinoma with Epstein-Barr virus infection.
J Virol
2002
76(13):6825-31
PubMed ID: 12050395
DOI: 10.1128/jvi.76.13.6825-6831.2002
|
|
5946
Sakakura C, Hagiwara A, Nakanishi M, Shimomura K, Takagi T, Yasuoka R, Fujita Y, Abe T, Ichikawa Y, Takahashi S, Ishikawa T, Nishizuka I, Morita T, Shimada H, Okazaki Y, Hayashizaki Y, Yamagishi H.
Differential gene expression profiles of gastric cancer cells established from primary tumour and malignant ascites.
Br J Cancer
2002
87(10):1153-61
PubMed ID: 12402156
DOI: 10.1038/sj.bjc.6600580
|
|
3772
Ijichi H, Ikenoue T, Kato N, Mitsuno Y, Togo G, Kato J, Kanai F, Shiratori Y, Omata M.
Systematic analysis of the TGF-beta-Smad signaling pathway in gastrointestinal cancer cells.
Biochem Biophys Res Commun
2001
289(2):350-7
PubMed ID: 11716479
DOI: 10.1006/bbrc.2001.5988
|
|
5950
Sato K, Sasaki K, Akiyama Y, Yamaguchi K.
Mass spectrometric high-throughput analysis of serum-free conditioned medium from cancer cell lines.
Cancer Lett
2001
170(2):153-9
PubMed ID: 11463493
DOI: 10.1016/s0304-3835(01)00567-5
|
|
5953
Matsumura M, Ijichi M, Shiratori Y, Togo G, Hikiba Y, Inoued K, Kohara M, Omata M.
Simple quantitative assay of alpha-fetoprotein mRNA in liver tissue using the real-time detection polymerase chain reaction assay - its application for clinical use.
Hepatol Res
2001
20(1):84-96
PubMed ID: 11282488
DOI: 10.1016/s1386-6346(00)00131-5
|
|
5958
Sakakura C, Hagiwara A, Yasuoka R, Fujita Y, Nakanishi M, Masuda K, Shimomura K, Nakamura Y, Inazawa J, Abe T, Yamagishi H.
Tumour-amplified kinase BTAK is amplified and overexpressed in gastric cancers with possible involvement in aneuploid formation.
Br J Cancer
2001
84(6):824-31
PubMed ID: 11259099
DOI: 10.1054/bjoc.2000.1684
|
|
15111
Togayachi A, Akashima T, Ookubo R, Kudo T, Nishihara S, Iwasaki H, Natsume A, Mio H, Inokuchi J, Irimura T, Sasaki K, Narimatsu H.
Molecular cloning and characterization of UDP-GlcNAc:lactosylceramide beta 1,3-N-acetylglucosaminyltransferase (beta 3Gn-T5), an essential enzyme for the expression of HNK-1 and Lewis X epitopes on glycolipids
J Biol Chem
2001
276(25):22032-40
PubMed ID: 11283017
DOI: 10.1074/jbc.M011369200
|
|
19063
Bai Y, Akiyama Y, Nagasaki H, Yagi OK, Kikuchi Y, Saito N, Takeshita K, Iwai T, Yuasa Y.
Distinct expression of CDX2 and GATA4/5, development-related genes, in human gastric cancer cell lines
Mol Carcinog
2000
28(3):184-8
PubMed ID: 10942535
DOI: 10.1002/1098-2744(200007)28:3<184::aid-mc7>3.0.co;2-6
|
|
5966
Sato H, Ishihara S, Kawashima K, Moriyama N, Suetsugu H, Kazumori H, Okuyama T, Rumi MA, Fukuda R, Nagasue N, Kinoshita Y.
Expression of peroxisome proliferator-activated receptor (PPAR)gamma in gastric cancer and inhibitory effects of PPARgamma agonists.
Br J Cancer
2000
83(10):1394-400
PubMed ID: 11044367
DOI: 10.1054/bjoc.2000.1457
|
|
6160
Jawhari AU, Noda M, Farthing MJ, Pignatelli M.
Abnormal expression and function of the E-cadherin-catenin complex in gastric carcinoma cell lines.
Br J Cancer
1999
80(3-4):322-30
PubMed ID: 10408833
DOI: 10.1038/sj.bjc.6690358
|
|
2194
Nishizuka S, Tamura G, Maesawa C, Sakata K, Suzuki Y, Iwaya T, Terashima M, Saito K, Satodate R
Analysis of the DPC4 gene in gastric carcinoma
Jpn J Cancer Res
1997
88:335-339
PubMed ID: 9197522
DOI: 10.1111/j.1349-7006.1997.tb00385.x
|
|
5973
Tamura G, Sakata K, Nishizuka S, Maesawa C, Suzuki Y, Iwaya T, Terashima M, Saito K, Satodate R.
Analysis of the fragile histidine triad gene in primary gastric carcinomas and gastric carcinoma cell lines.
Genes Chromosomes Cancer
1997
20(1):98-102
PubMed ID: 9290961
|
Back
Top
CELL BANK Website
